Orgenesis (NASDAQ:ORGS) reported quarterly earnings of $0.05 per share. This is a 88.1 percent decrease over earnings of $0.42 per share from the same period last year.
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.